Osaic Holdings’s iRadimed IRMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$532K Sell
5,525
-822
-13% -$82.2K ﹤0.01% 3287
2025
Q4
$617K Buy
6,347
+3,018
+91% +$259K ﹤0.01% 3147
2025
Q3
$240K Sell
3,329
-484
-13% -$32.2K ﹤0.01% 4065
2025
Q2
$228K Buy
3,813
+3,373
+767% +$185K ﹤0.01% 3832
2025
Q1
$23.1K Sell
440
-278
-39% -$15.6K ﹤0.01% 5250
2024
Q4
$39.5K Buy
718
+31
+5% +$1.63K ﹤0.01% 4868
2024
Q3
$34.6K Buy
687
+63
+10% +$2.91K ﹤0.01% 5007
2024
Q2
$27.4K Buy
624
+123
+25% +$5.23K ﹤0.01% 5121
2024
Q1
$22K Sell
501
-51
-9% -$2.25K ﹤0.01% 5305
2023
Q4
$26.3K Sell
552
-62
-10% -$2.61K ﹤0.01% 5334
2023
Q3
$27.3K Buy
614
+10
+2% +$465 ﹤0.01% 5383
2023
Q2
$28.9K Buy
604
+1
+0.2% +$45 ﹤0.01% 5310
2023
Q1
$23.8K Sell
603
-474
-44% -$17.2K ﹤0.01% 5475
2022
Q4
$30.5K Sell
1,077
-110
-9% -$3.15K ﹤0.01% 5281
2022
Q3
$37K Buy
1,187
+20
+2% +$697 ﹤0.01% 5126
2022
Q2
$40K Sell
1,167
-1,000
-46% -$35.8K ﹤0.01% 5121
2022
Q1
$98K Buy
2,167
+978
+82% +$45.2K ﹤0.01% 4609
2021
Q4
$55K Buy
1,189
+950
+397% +$38.3K ﹤0.01% 5075
2021
Q3
$8K Buy
239
+220
+1,158% +$7.48K ﹤0.01% 6327
2021
Q2
$1K Hold
19
﹤0.01% 6854
2021
Q1
$0 Buy
+19
New +$454 ﹤0.01% 6875
2020
Q4
Sell
-50
Closed -$1K 6485
2020
Q3
$1K Buy
+50
New +$1.12K ﹤0.01% 6020
2020
Q2
Sell
-600
Closed -$13K 6213
2020
Q1
$13K Buy
+600
New +$14.3K ﹤0.01% 4867

Other funds holding IRMD

Osaic Holdings's IRMD Position: Q1 2026 in Review

Osaic Holdings reduced its iRadimed (IRMD) stake by 13% in Q1 2026, selling an estimated $82.2K and leaving 5,525 shares worth $532K. The position accounts for ﹤0.01% of the portfolio, ranked #3287.

Osaic Holdings first reported a position in IRMD in Q1 2020 and has held it in 23 quarters since. The position peaked at $617K in Q4 2025. 228 funds tracked by Wall St. Rank hold IRMD as of Q1 2026.

  • Osaic Holdings held 5,525 shares of iRadimed worth $532K as of Q1 2026.
  • Osaic Holdings sold 822 iRadimed shares in Q1 2026, an estimated $82.2K.
  • iRadimed made up ﹤0.01% of Osaic Holdings's portfolio in Q1 2026, its #3287 holding.
  • Osaic Holdings first reported a position in iRadimed in Q1 2020 and has held it in 23 quarters since.
  • Osaic Holdings's iRadimed position peaked at $617K in Q4 2025.
  • 228 funds tracked by Wall St. Rank held iRadimed as of Q1 2026.

Based on Osaic Holdings's 13F filing for Q1 2026, filed 15 May 2026.